Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy
- Address
- Alpejska 42
Sponsor Overview
Specializations
Structural Heart Interventions and Periprocedural Anticoagulation
Research activity includes anticoagulation management around transseptal structural procedures, with attention to Transcatheter Edge-to-Edge Repair and Left Atrial Appendage Closure. The focus is on balancing thromboembolic protection and bleeding risk in patients undergoing invasive cardiac intervention.
- Transseptal cardiac procedures
- Anticoagulant therapy
- Stroke prevention
- Bleeding risk management
Additional interest extends to antiplatelet strategies after left atrial appendage closure in patients with complex cardiovascular comorbidity.
Coronary Artery Disease, Atherosclerosis, and Prediabetes
Clinical research covers coronary disease linked with metabolic risk, including coronary atherosclerosis and prediabetes. The therapeutic landscape centers on cardiovascular risk reduction and plaque-related disease progression.
- Coronary artery disease
- Coronary atherosclerosis
- Metabolic cardiology
- Anti-atherosclerotic treatment
Interest also includes oral glucose-lowering therapies with cardiovascular relevance, especially in relation to coronary plaque burden assessed over time.
Hypertrophic Cardiomyopathy and Atrial Fibrillation
A major area of focus is hypertrophic cardiomyopathy, particularly when complicated by atrial fibrillation and reduced functional capacity. The research portfolio addresses rhythm control, arrhythmia prevention, and exercise limitation in this inherited cardiac condition.
- Atrial fibrillation prevention
- Rhythm control strategies
- Exercise capacity
- Inherited cardiomyopathy
There is also interest in therapies aimed at maintaining sinus rhythm and limiting arrhythmic complications in patients with structural heart disease.
Fontan Circulation and Congenital Heart Disease
Research includes adults with functionally single ventricle physiology after Fontan operation, where the emphasis is on circulatory support and physical performance. This area reflects ongoing work in complex congenital heart disease.
- Fontan circulation
- Single ventricle physiology
- Exercise intolerance
- Pulmonary vascular resistance
Therapeutic interest also includes hemodynamic optimization in patients living with long-term consequences of congenital cardiac surgery.
Hypertension, Antiplatelet Therapy, and Arrhythmogenic Cardiomyopathy
The sponsor also studies difficult-to-treat hypertension, antiplatelet management in high-risk cardiovascular patients, and disease-modifying approaches in arrhythmogenic cardiomyopathy. These topics reflect a broad interest in vascular control, thrombosis prevention, and myocardial remodeling.
- Resistant hypertension
- Dual and single antiplatelet therapy
- Arrhythmogenic cardiomyopathy
- Cardiac remodeling
Related work includes treatment pathways for patients with renal impairment who require long-term cardiovascular antithrombotic care.
Sponsored Trials
Data & Insights
This sponsor works with 23 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 31 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases9 trials359 other sponsors
- 2.Circulatory and Respiratory Physiological Phenomena1 trial16 other sponsors
- 3.Congenital, Hereditary, and Neonatal Diseases and Abnormalities1 trial165 other sponsors
- 4.Physiological processes1 trial28 other sponsors
Partnered Research Centres
31 centres- Address
- Ul. Aleje Raclawickie 23, 20-049 Lublin
- Address
- ul. Poniatowskiego 15, 86-300 Grudziądz
- Address
- ul. Terespolska 12, 08-110 Siedlce
- Address
- Ul. Ziolowa 45/47, 40-635 Katowice
- Address
- Ul. Pradnicka 80, 31-202 Krakow
- Address
- ul Kościuszki 2A, 37-200 Przeworsk
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego Panstwowy Instytut Badawczy.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.